Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug
Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...
Drinking. Gambling. Online shopping. Researchers are exploring if obesity drugs could curb cravings beyond food.
GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...
About half of Americans approve of using weight-loss drugs to treat obesity, new poll finds
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...
Americans split on using weight loss drugs to treat obesity: Survey
Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...
STAT1d
Pharmalittle: We’re reading about an FDA hold on an Amgen obesity drug, imported Canadian drugs, and more
The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...
What is front-of-package food labeling? And will it help?
Earlier this month, the U.S. Food and Drug Administration proposed food companies use new, front-of-package labels highlighting the levels of fat, salt and added sugar in their products.
News Medical on MSN3d
Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs
Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...
Hosted on MSN1d
Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs
Amgen stock rose early Wednesday, though the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...